跳至主要内容
临床试验/CTRI/2021/10/037654
CTRI/2021/10/037654已完成未知

Serum TSH level : A competent tool for assessing risk of malignancy of thyroid nodules with indeterminate cytology in euthyroid patients

Amrita Institute of Medical Sciences0 个研究点目标入组 304 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
304

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All euthyroid patients who underwent thyroid surgery for newly diagnosed thyroid nodules with FNAC reported as indeterminate cytology (Bethesda III) were included in our study.

排除标准

  • Patients, other than Bethesda class III or those already diagnosed with thyroid malignancy were excluded from the study. Other exclusion criteria were patients on thyroid hormone supplementation and Serum TSH level not within the euthyroid range.

研究者

相似试验